Our Experts

Private Health has convened a multidisciplinary consortium of experts to provide the Film and TV industry with the guidelines and tools to responsibly navigate production during the complex COVID-19 pandemic. 

Private Health Management Network

Medical/Public Health

Dr. Cedric “Jamie” Rutland, MD

COVID-19 Medical Director for Private Health Management. Dr. Rutland is triple Board Certified in Internal Medicine, Pulmonary and Critical Care. He is a leading expert in the medical management of patients with complex respiratory diseases, including the treatment of patients with COVID-19 at all stages of the disease. He is the national spokesperson for the American Lung Association and is the Assistant Clinical Professor of Internal Medicine at UCR School of Medicine. 

Dr. Robert R. Simon, MD

Medical Director for Private Health Management. Dr. Simon is an expert in the diagnosis and management of complex cases including chronic pain and orthopedic issues. He is a Professor of Emergency Medicine at Rush University, Medical Center, and Executive Chair of Emergency Medicine for Cook County hospitals. Dr. Simon is also the Founder and Chair of International Medical Corps.

Dr. Marc Suchard, MD, PhD

UCLA Professor at the Biostatics Fielding School of Public Health and Bio Mathematics & Human Genetics at the David Geffen School of Medicine. Dr. Suchard was a key contributor to the development of the PHM COVID-19 Intervention Model and an active infectious disease researcher. Specializes in biomathematical and biostatistical approaches to advance the study of rapidly evolving pathogens. Named one of the most influential scientific researchers by Clarivate Analytics. 

Dr. David G. Ng, MD

Critical Care and Pulmonologist Expert. Dr. Ng is Board Certified in Internal Medicine with subspecialties in Critical Care and Pulmonology. Dr. Ng specializes in the diagnosis and management of respiratory diseases and disorders and has treated COVID-19 patients. He remains active in education and was recently given the Golden Apple Award in appreciation for excellence in teaching and outstanding contributions to medical education from the Internal Medical Training Program at Cedars Sinai.  

Jennifer Peña, ACNP-BC

Vice President of Clinical Services at Private Health Management. Jennifer leads the COVID-19 clinical care response team. Jennifer is a Board Certified Acute Care Nurse Practitioner. She has extensive nursing experience including medical-surgical, critical care, emergency room, occupational health and wellness, and organ transplant experience. She holds certifications in triage and PICC as well as Acute/Critical Care Knowledge by the American Association of Critical-Care Nurses.

Laura Kusminsky, PA-C

Senior Director, Clinical Services at Private Health Management. Laura provides clinical leadership for COVID-19 Health Safety Departments and serves as a Health Safety Supervisor for on-set Film and TV productions. She also provides clinical leadership for the Enterprise Health Services Program at Private Health Management. Laura is a Board Certified Physician Assistant with a strong clinical background in internal medicine and oncology.

Karin Kessey, MSPAS, PA-C

Director of Clinical Services at Private Health Management. Karin is a COVID-19 Health Safety Officer for Film and TV onset Health Safety Departments. She is a Board Certified Physician Assistant with surgical training focused in the Trauma and Intensive Care Unit setting. She has 7+ years of clinical experience as an emergency medicine and neurology advanced practitioner.

Research and Modeling

Dr. Christina M. Ramirez, PhD

Professor of Biostatistics at the UCLA Fielding School of Public Health. Dr. Ramirez is an expert in statistical modeling of infectious diseases. She developed the COVID-19 PHMC19 Intervention Model and advises clients on the likely impact of the virus across their workplaces and workforce. Dr. Ramirez is renowned for her research and statistical modeling of infectious diseases including HIV, Nipah, and Ebola. She has multiple Clinical Laboratory Improvement Amendments licensed and FDA-approved patents.

Dr. Eva J. Gordon, PhD

Vice President of Research at Private Health Management. Dr. Gordon leads all research efforts on COVID-19 including evaluating emerging testing options and providing science-backed, independent recommendations to clients. Dr. Gordon has extensive experience as a medical researcher and science writer, with much of her career focusing on cancer and immunology. As a Damon Runyon-Walter Winchell Postdoctoral Fellow at Harvard Medical School, Dr. Gordon studied how viruses evade detection from the immune system.

Dr. Natalya Gertsik, PhD

Director, Research and Analytics at Private Health Management. Dr. Gertsik is the lead consultant on COVID-19 corporate recovery engagements, providing clients across an array of industries, with customized solutions to manage COVID-19 health risk. She is an expert in designing precision medicine treatment strategies in oncology, based on the latest scientific advances. Dr. Gertsik received her doctorate in biochemistry from Weill Cornell and worked as a consultant at McKinsey & Company.

Nicholas Argento

Director of Executive Services and Provider Relations at Private Health Management. He specializes in connecting renowned healthcare providers and clients to ensure the highest level of care and coordination. He leads Private Health Management’s comprehensive COVID-19 Testing Solution and designs production-specific testing protocols.

Jonathan Han, MPH

Research Analyst at Private Health Management. Jonathan leads research and provides guidance on the latest COVID-19 developments to help clients balance business and public health decisions. He has specifically led the development of our COVID-19 quarantine and contact tracing protocols. Jonathan has a background in biostatistics, epidemiology and public health.

Film and TV Production

Brian T. Edwards

Head of Productions Services at Private Health Management. Brian leads the COVID-19 Film, TV and Entertainment teams for Private Health Management and is the production liaison. He has 30+ years experience with technical production support and logistics with PRG (including OBLIVION, HOUSE OF CARDS, SUPER BOWL HALF TIME SHOW, OLYMPIC CEREMONIES), Steiner Studios and Paramount Studios, LA. As a first responder on 9/11, he worked directly with the FDNY to provide emergency services at Ground Zero.

Rodney Faraon

Partner at Martin+Crumpton Group. Rodney advises clients on managing risk factors related to COVID-19 in the production environment. He was the founding director of global intelligence and threat analysis at The Walt Disney Company, executive producer for a prime time show on broadcast network television and an advisor, consultant, and writer for Film and TV including HOMELAND, THE CROSSING, THE BLACKLIST and THE BILLION DOLLAR SPY. He is a Member of the Producers Guild of America and Television Academy.

Aaron King

Project Manager at Private Health Management. Aaron was the engagement lead for the COVID-19 De-Risking program for one of the first films to return to production following the COVID-19 shutdown. He is an Emmy Award-winning Art Director and Production Designer. He has managed more than 100 major international productions including film, theater, commercials, episodic and special events. His professional memberships include The Art Directors Guild Local 800, I.A.T.S.E, and The Academy of Television Arts and Sciences.


Gregg S. Britt

Co-Founder and CEO at Private Health Management. Gregg has 20+ years of leadership experience in health care, health research, and drug development industries. He is the founder of Innovis, LLC, a leading provider of strategic consulting and product development services across the medical industry. Gregg was also the former CEO, AIDS Research Alliance of America, and the SVP of Biopharmaceutical Research and Development for the Prostate Cancer Foundation.

Kenneth Sawka

President of Martin+Crumpton Group. Ken has 30+ years of C-Suite and Board level management consulting, public sector, academic experience. He has designed and led scenario planning, intelligence training, and coaching for public and private sector organizations around the world. He was an intelligence analyst with the Central Intelligence Agency, CEO of Fuld + Company, and Senior Manager at Deloitte’s Global Strategy and Operations practice.

Mark Oshima

Executive Vice President, Enterprise Solutions at Private Health Management. Mark has 20+ years of global leadership experience. He has the proven ability to drive business strategy and growth, optimize operational processes, achieve results, and build high performing organizations and teams. He spent more than two decades at Aon and Aon Hewitt in both executive leadership and client leadership roles.


Julia Richter

Vice President, COVID-19 Testing Solutions at Private Health Management. Julia has 15+ years of leadership, brand management and client engagement experience across multiple industries on top-tier brands. She leads all efforts related to COVID-19 Testing Solutions, overseeing the creation, evolution and realization of testing strategies and implementation approaches, from corporate group testing events to our new RT-PCR self-swab sample collection service with 24 hour turnaround from lab receipt. Julia leads multiple COVID-19 accounts, harnessing cross-functional teams to solve clients’ pandemic-related challenges.

Robert Flynn

Principal of Risk Management Services at Martin+Crumpton Group. Bob has 30+ years of experience in risk management and strategy across businesses, academic, and not-for-profit enterprises including Travelers Insurance, Aetna, BNY Mellon, Deloitte, and the Connecticut State Governor’s Office. He spent 13+ years as an intelligence officer at the Central Intelligence Agency, where he conducted worldwide risk assessments of U.S. operations.

Additional Consortium Expertise

Private Health Management’s COVID-19 Consortium includes medical, risk and production experts who bring together medical insight, governmental and business intelligence analysis, proprietary biostatistical modeling and risk management to provide customized, actionable guidance to TV and Film productions.